Fast-Acting Nasal Spray Approved To Treat Suicidal People

0
>>Follow Matzav On Whatsapp!<<

Johnson & Johnson’s Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about Covid-19’s effect on the mental health of Americans.

The Food and Drug Administration approval means the quick-acting nasal spray will be available to people with suicidal thoughts and a plan to put them into action, said Michelle Kramer, vice president of J&J’s U.S. neuroscience medical-affairs unit. That constitutes 11% to 12% of as many as 17 million Americans who have major depressive disorder.

Read more at Bloomberg

{Matzav.com}


LEAVE A REPLY

Please enter your comment!
Please enter your name here